Wednesday, 28 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Suven Life Sciences Financial Results

Suven Life Sciences reported audited financial results for FY26. The Board also noted a fine waiver from BSE and scheduled its 37th AGM for August 2026.

Source

NSE filing, NSE: SUVEN. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Suven Life Sciences Ltd: key numbers

Share price
₹268.05
Market cap
₹7,574 Cr
Revenue (annual)
₹7.11 Cr
Net profit (annual)
₹-276.3 Cr
P/E (TTM)
-21.5×Sector 52.0×
Promoter holding
65.47%-4.61% QoQ
FII holding
0.45%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Suven Life Sciences Ltd

All →

Other financial results announcements

All →